This inventor holds 2 USPTO granted patents. Top assignees: Merck Sharp + Dohme Corp., Merck Sharp + Dohme B.v.. Active years: 2021-2022.
Location History:
- Princeton, NJ (US) (2021)
- Collegeville, PA (US) (2022)
Company Filing History:

Years Active: 2021-2022
Title: Himanshu Bhattacharjee: Innovator in Pharmaceutical Compositions
Introduction
Himanshu Bhattacharjee is a notable inventor based in Princeton, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. With a total of 2 patents, his work focuses on addressing critical health issues such as diabetes and HIV.
Latest Patents
Himanshu's latest patents include groundbreaking pharmaceutical compositions. One patent discloses pharmaceutical compositions comprising a peptide of SEQ ID No. 1, or a pharmaceutically acceptable salt or counterion thereof. This invention also outlines methods for preparing these compositions and their application in treating diabetes and diabetes-related disorders. Another patent presents formulations for parenteral administration, specifically a long-acting injectable drug product that includes a suspension of doravirine. This formulation is designed for intramuscular or subcutaneous administration and is intended for the treatment or prophylaxis of HIV infection, as well as for managing AIDS and AIDS-related complex.
Career Highlights
Himanshu has worked with prominent companies in the pharmaceutical industry, including Merck Sharp & Dohme Corp. and Merck Sharp & Dohme B.V. His experience in these organizations has allowed him to contribute to the development of innovative healthcare solutions.
Collaborations
Some of his notable coworkers include Sachin Mittal and Suzanne M D'Addio. Their collaboration has likely played a role in advancing the research and development of pharmaceutical innovations.
Conclusion
Himanshu Bhattacharjee is a distinguished inventor whose work in pharmaceutical compositions has the potential to significantly impact healthcare. His contributions to drug formulations demonstrate his commitment to addressing critical health challenges.